KIF20A Drives Anti-PD-1 Resistance in NSCLC
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
In the ever-evolving landscape of cancer immunotherapy, one of the most formidable challenges remains the innate resistance some tumors exhibit ...
Recent advancements in cancer therapeutics have brought to light an extraordinary small molecule, identified as the 3,4-diisobutyryl derivative of auxarthrol ...
Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant NSCLC: Unraveling the Complex Landscape of Therapeutic Evasion In the relentless battle ...
In the relentless pursuit of innovative cancer therapies, scientific researchers are increasingly turning their attention to molecular pathways that govern ...
In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled the potential of Ginsenoside Rh2 as ...
In recent years, the landscape of cancer treatment has been dramatically transformed by immunotherapy, offering new hope to patients with ...
In recent years, the landscape of non-small cell lung cancer (NSCLC) treatment has undergone a significant transformation, driven primarily by ...
In an innovative breakthrough study published in BMC Cancer, researchers have unveiled that systemic inflammation biomarkers may hold the key ...
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a ...
In the relentless battle against non-small cell lung cancer (NSCLC), radiotherapy (RT) stands as a indispensable weapon. However, like many ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine